 |
 close |
|||||
|
|
August 25, 2006 Octapharma to Sponsor Symposium at ISBT Congress, Sept 2-7, in Cape Town, South Africa
Octapharma will sponsor a lunchtime satellite symposium on Sept 5th and participate in the exhibition with a 36sqm booth (number 45). Delegates will be invited to join us on the booth for a challenging quiz and the opportunity to learn more about Octaplas, our pharmaceutically licensed, proven alternative to fresh frozen plasma. The lunchtime satellite symposium, FFP or Biopharmaceutical Plasma - A Real Therapeutic Dilemma? will consider the pros and cons for the two types of products, and will include presentations that explore factors affecting efficacy, pathogen safety, adverse events, and tolerability . Information concerning the production of FFP and biopharmaceutical plasma along with evidence from clinical studies and haemocovigilance data will be presented. The particular case of Transfusion-Related Acute Lung Injury (TRALI) will contribute to the discussion on adverse events, while, a look at the option to use universal plasma and its potential benefits will be explored as well. The symposium program and speakers names are presented below. You may also download the invitation to the symposium and the Book of Abstracts.
Chairman: Prof. Bjarte Solheim, Norway Octaplas: GMP Manufacturing – Quality & Safety Standards. Mr. Tor-Einar Svae, Austria FFP or Biopharmaceutical Plasma: How to Decide Prof Peter Hellstern, Germany Adverse Reactions of Plasma Transfusion; a Particular Case: TRALI Dr. Ulrich Sachs, Germany Experiences with Universal Biopharmaceutical Plasma Ms. Carolyn Rochat, South Africa Symposium Invitation  (1 MB)
Symposium Book of Abstracts ISBT Congress Website |
